Flowers Foods (FLO) Q1 2026 Prepared Remarks earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 Prepared Remarks earnings summary
26 Aug, 2026Executive summary
Net sales rose 1.1% year-over-year to $1.572 billion, driven by the Simple Mills acquisition and favorable pricing/mix, offsetting volume declines and higher operating costs.
Net income fell 20.6% to $42.1 million, with adjusted net income down 17.4% to $60.9 million, reflecting a challenging consumer environment and higher interest expense.
Adjusted EBITDA decreased 1.8% to $159.0 million, representing 10.1% of net sales.
Comprehensive review of brand portfolio, supply chain, and financial strategy is ongoing, sharpening focus on core brands and targeted investments.
Relaunched Nature's Own with simpler ingredients and a national marketing campaign, now the largest Non-GMO Project Verified loaf at national scale.
Financial highlights
Branded retail net sales increased 3.4% to $1.045 billion, driven by pricing/mix and Simple Mills acquisition, despite a 4.2% volume decline; other net sales decreased 3.1%.
Gross margin (excluding D&A) was 49.4%, down 50 basis points year-over-year due to lower volumes and increased outside purchases.
GAAP diluted EPS was $0.20, down $0.05; adjusted diluted EPS was $0.29, down from $0.35 year-over-year.
Cash flow from operations was $107.9 million, down $27.8 million; capex was $20.6 million, down $4.9 million; dividends paid were $54.4 million.
Interest expense increased 39.8% to $19.6 million due to debt issued for the Simple Mills acquisition.
Outlook and guidance
Fiscal 2026 net sales expected between $5.163 billion and $5.267 billion, a change of -1.8% to 0.2% year-over-year.
Adjusted EBITDA projected at $465 million to $495 million; adjusted diluted EPS forecasted at $0.80 to $0.90.
Capital expenditures anticipated at $115 million to $125 million; effective tax rate around 26%.
Guidance reflects category headwinds, promotional environment, cost savings initiatives, and normalization of bonus compensation.
Near-term top-line outlook remains cautious due to soft category trends and inflationary pressures.
Latest events from Flowers Foods
- Net sales fell 4% and adjusted EBITDA dropped 19% as cost actions and innovation accelerate.FLO
Q2 2026 Prepared Remarks - Sales and earnings declined, but innovation and cost savings support the outlook.FLO
Q2 2026 (Q&A) - Q4 sales up 11% but a $136M impairment drove a net loss; 2026 outlook remains cautious.FLO
Q4 2025 Prepared Remarks - Net sales up 3% as premium brands and acquisitions offset profit declines from higher costs.FLO
Q3 2025 Prepared Remarks - Sales rose 1.5% on branded and M&A gains, but margins and guidance fell on cost and market pressures.FLO
Q2 2025 Prepared Remarks - Net income fell 27.4% as sales declined 1.4%, but adjusted EBITDA rose on margin gains.FLO
Q1 2025 Prepared Remarks - Net income jumped to $65M on margin gains and lower legal costs, despite a sales decline.FLO
Q3 2024 Prepared Remarks - Net income and margins rose in Q2 2024 despite flat sales, with FY guidance reaffirmed.FLO
Q2 2024 Prepared Remarks - Margin gains and premium product growth offset sales declines amid a cautious 2025 outlook.FLO
Q4 2024 Prepared Remarks